journal article·2023-10-11Open access

Cytoplasm Hydrogelation-Mediated Cardiomyocyte Sponge Alleviated Coxsackievirus B3 Infection

Jingzhe Wang, Tonggong Liu, Siyao Gu, Hui-hui Yang, Weidong Xie, Cheng Gao, Dayong Gu

Nano Letters· Volume 23· Issue 19

Abstract

Viral myocarditis (VMC), commonly caused by coxsackievirus B3 (CVB3) infection, lacks specific treatments and leads to serious heart conditions. Current treatments, such as IFNα and ribavirin, show limited effectiveness. Herein, rather than inhibiting virus replication, this study introduces a novel cardiomyocyte sponge, intracellular gelated cardiomyocytes (GCs), to trap and neutralize CVB3 via a receptor–ligand interaction, such as CAR and CD55. By maintaining cellular morphology, GCs serve as sponges for CVB3, inhibiting infection. In vitro results revealed that GCs could inhibit CVB3 infection on HeLa cells. In vivo, GCs exhibited a strong immune escape ability and effectively inhibited CVB3-induced viral myocarditis with a high safety profile. The most significant implication of this study is to develop a universal antivirus infection strategy via intracellular gelation of the host cell, which can be employed not only for treating defined pathogenic viruses but also for a rapid response to infection outbreaks caused by mutable and unknown viruses.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Viral Infections and Immunology Research · Cardiac Structural Anomalies and Repair · Cytomegalovirus and herpesvirus research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Laboratory Medicine, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen Key Laboratory of Medical Laboratory and Molecular Diagnostics, Shenzhen 518035, China

Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

Shenzhen Key Laboratory of Health Science and Technology, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China

Funding

Science and Technology Planning Project of Guangdong Province · National Key Research and Development Program of China · Basic and Applied Basic Research Foundation of Guangdong Province · China Postdoctoral Science Foundation · Science, Technology and Innovation Commission of Shenzhen Municipality · National Natural Science Foundation of China

References (38)

Show source-provided references
1. 10.1126/sciadv.aaz243310.1126/sciadv.aaz2433 ↗
2. 10.2337/dc20-109210.2337/dc20-1092 ↗
3. 10.1016/j.chom.2009.05.01810.1016/j.chom.2009.05.018 ↗
4. 10.1080/15548627.2021.189692510.1080/15548627.2021.1896925 ↗
5. 10.1016/j.jacc.2013.05.07610.1016/j.jacc.2013.05.076 ↗
6. 10.1016/j.yjmcc.2018.08.02910.1016/j.yjmcc.2018.08.029 ↗
7. 10.1021/acs.chemrev.9b0074610.1021/acs.chemrev.9b00746 ↗
8. 10.1038/nm.258110.1038/nm.2581 ↗
9. 10.1128/JVI.02575-1310.1128/JVI.02575-13 ↗
10. 10.1084/jem.2020118110.1084/jem.20201181 ↗
11. 10.1038/s41467-020-18387-810.1038/s41467-020-18387-8 ↗
12. 10.1038/s41467-021-24230-510.1038/s41467-021-24230-5 ↗
13. 10.1002/jmv.2800610.1002/jmv.28006 ↗
14. 10.1038/s41467-021-27610-z10.1038/s41467-021-27610-z ↗
15. 10.3389/fchem.2020.0019510.3389/fchem.2020.00195 ↗
16. 10.3389/fimmu.2022.99903410.3389/fimmu.2022.999034 ↗
17. 10.3390/biomedicines1011282010.3390/biomedicines10112820 ↗
18. 10.3892/ijmm.2017.300810.3892/ijmm.2017.3008 ↗
19. 10.1016/j.chom.2021.01.00110.1016/j.chom.2021.01.001 ↗
20. 10.1128/JVI.01054-1910.1128/JVI.01054-19 ↗
21. 10.1126/science.121871310.1126/science.1218713 ↗
22. 10.1038/s41467-020-16439-710.1038/s41467-020-16439-7 ↗
23. 10.1002/adhm.20170136610.1002/adhm.201701366 ↗
24. 10.1021/acs.nanolett.8b0391310.1021/acs.nanolett.8b03913 ↗
25. 10.1002/adma.20180223310.1002/adma.201802233 ↗
26. 10.1016/j.jacc.2016.09.93710.1016/j.jacc.2016.09.937 ↗
27. 10.1016/j.biomaterials.2013.07.05210.1016/j.biomaterials.2013.07.052 ↗
28. 10.1126/sciadv.abc301310.1126/sciadv.abc3013 ↗
29. 10.3389/fcvm.2021.77054910.3389/fcvm.2021.770549 ↗
30. 10.1093/jleuko/qiad04810.1093/jleuko/qiad048 ↗
31. 10.1016/j.carbpol.2020.11718710.1016/j.carbpol.2020.117187 ↗
32. 10.1016/j.ebiom.2020.10265610.1016/j.ebiom.2020.102656 ↗
33. 10.1002/advs.20210590410.1002/advs.202105904 ↗
34. 10.1021/acs.nanolett.0c0227810.1021/acs.nanolett.0c02278 ↗
35. 10.1002/adma.20210771910.1002/adma.202107719 ↗
36. 10.1038/s41577-019-0200-110.1038/s41577-019-0200-1 ↗
37. 10.1128/JVI.76.22.11440-11446.200210.1128/JVI.76.22.11440-11446.2002 ↗
38. 10.1007/s10439-016-1583-910.1007/s10439-016-1583-9 ↗